MNPR Operating Cash Flow (Statement)

Monopar Therapeutics Inc · Operating Cash Flow (Statement)

MNPR logo

MNPR Operating Cash Flow (Statement)

Latest reported-$3.26B
MNPR TTM Cash from Operations (-$1.19M → -$3.26B)
High-resolution chart · PNG

MNPR operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monopar Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-3,256,371,510
-10,011,881
-12,201,291
-10,829,637
-9,812,605
-10,412,032
-6,404,139
-5,951,620
-6,817,933
-7,242,603
-7,858,293
-7,614,200
-7,822,865
-6,988,710
-7,185,097
-7,915,196
-7,708,034
-7,846,841
-7,317,401
-6,526,192
-5,885,410
-5,474,764
-4,662,274
-4,090,282
-3,403,016
-3,147,277
-3,017,679
-3,074,457
-3,060,752
-3,073,880
-2,886,757
-2,977,296
-3,572,566
-3,124,831
-2,627,468
-2,278,780
-1,296,375
-1,248,682
-1,194,632
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.